Search results
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto
Morningstar· 4 days agoThe biotechnology company on Friday said the approval is aimed at adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic ...
What does malignant mean? And why it matters greatly when it comes to tumors and your health.
USA Today· 3 days agoEducation is everything when it comes to receiving a cancer diagnosis. For instance, understanding...
CAR-T cell therapy to treat blood cancers unlikely to increase risk of secondary cancers
UPI· 6 days agoA study of more than 700 patients treated at Stanford University found that the risk of secondary ...
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Zacks· 2 days agoALL is a fast-growing type of blood cancer that develops in the bone marrow. Consolidation treatment is given to cancer</ ...
Community leaders hosting fundraiser for 8-year-old leukemia patient
The Norman Transcript, Okla. via Yahoo News· 6 days agoNorman community members and sponsors will host a fundraising event this Saturday in hopes of alleviating the financial burden for a student who was recently diagnosed with a form of
To Your Good Health: The cause behind a case of CMML seems to be unknown
The Marshall News Messenger· 5 days agoAccording to his death certificate, he died of lung cancer (not a surprise) and chronic...
...POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)...
Morningstar· 4 days agoFood and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative ...
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
The Yuma Sun· 5 days ago- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, including those receiving prior venetoclax
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 5 days agoThe report details the case of a 71-year-old woman with a history of multiple myeloma, a type of ...
What Is a T-Cell Lymphoproliferative Disorder? Inside Halsey's Diagnosis
Health.com· 7 days agoHalsey, 29, was diagnosed and treated for both lupus and a rare white blood cell disorder, according...